These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35114010)

  • 1. Serum Neurofilament Light Chain as a Biomarker of Brain Injury in Wilson's Disease: Clinical and Neuroradiological Correlations.
    Ziemssen T; Akgun K; Członkowska A; Antos A; Bembenek J; Kurkowska-Jastrzębska I; Przybyłkowski A; Skowrońska M; Smolinski L; Litwin T
    Mov Disord; 2022 May; 37(5):1074-1079. PubMed ID: 35114010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Neurofilament Light Chain in Wilson's Disease: A Promising Indicator but Unparallel to Real-Time Treatment Response.
    Wang RM; Xu WQ; Zheng ZW; Yang GM; Zhang MY; Ke HZ; Xia N; Dong Y; Wu ZY
    Mov Disord; 2022 Jul; 37(7):1531-1535. PubMed ID: 35507442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson's disease.
    Ziemssen T; Smolinski L; Członkowska A; Akgun K; Antos A; Bembenek J; Kurkowska-Jastrzębska I; Przybyłkowski A; Skowrońska M; Redzia-Ogrodnik B; Litwin T
    Acta Neurol Belg; 2023 Jun; 123(3):917-925. PubMed ID: 36098934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain Atrophy Is Substantially Accelerated in Neurological Wilson's Disease: A Longitudinal Study.
    Smolinski L; Ziemssen T; Akgun K; Antos A; Skowrońska M; Kurkowska-Jastrzębska I; Członkowska A; Litwin T
    Mov Disord; 2022 Dec; 37(12):2446-2451. PubMed ID: 36165286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma neurofilament light chain as a biomarker in Wilson's disease.
    Yang J; Huang Z; Yang H; Luo Y; You H; Chen D; Pei Z; Li X
    Parkinsonism Relat Disord; 2022 Feb; 95():5-10. PubMed ID: 34942565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Neurofilament Light as a Biomarker of Neurological Involvement in Wilson's Disease.
    Shribman S; Heller C; Burrows M; Heslegrave A; Swift I; Foiani MS; Gillett GT; Tsochatzis EA; Rowe JB; Gerhard A; Butler CR; Masellis M; Bremner F; Martin A; Jung L; Cook P; Zetterberg H; Bandmann O; Rohrer JD; Warner TT
    Mov Disord; 2021 Feb; 36(2):503-508. PubMed ID: 33078859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroimaging correlates of brain injury in Wilson's disease: a multimodal, whole-brain MRI study.
    Shribman S; Bocchetta M; Sudre CH; Acosta-Cabronero J; Burrows M; Cook P; Thomas DL; Gillett GT; Tsochatzis EA; Bandmann O; Rohrer JD; Warner TT
    Brain; 2022 Mar; 145(1):263-275. PubMed ID: 34289020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain magnetic resonance imaging and severity of neurological disease in Wilson's disease - the neuroradiological correlations.
    Rędzia-Ogrodnik B; Członkowska A; Bembenek J; Antos A; Kurkowska-Jastrzębska I; Skowrońska M; Smoliński Ł; Litwin T
    Neurol Sci; 2022 Jul; 43(7):4405-4412. PubMed ID: 35275318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain volume is related to neurological impairment and to copper overload in Wilson's disease.
    Smolinski L; Litwin T; Redzia-Ogrodnik B; Dziezyc K; Kurkowska-Jastrzebska I; Czlonkowska A
    Neurol Sci; 2019 Oct; 40(10):2089-2095. PubMed ID: 31147855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Measurement of Metal Accumulation in Brain of Patients With Wilson's Disease.
    Li G; Wu R; Tong R; Bo B; Zhao Y; Gillen KM; Spincemaille P; Ku Y; Du Y; Wang Y; Wang X; Li J
    Mov Disord; 2020 Oct; 35(10):1787-1795. PubMed ID: 32681698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroimaging Correlates of Cognitive Deficits in Wilson's Disease.
    Shribman S; Burrows M; Convery R; Bocchetta M; Sudre CH; Acosta-Cabronero J; Thomas DL; Gillett GT; Tsochatzis EA; Bandmann O; Rohrer JD; Warner TT
    Mov Disord; 2022 Aug; 37(8):1728-1738. PubMed ID: 35723521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered large-scale functional brain networks in neurological Wilson's disease.
    Jing R; Han Y; Cheng H; Han Y; Wang K; Weintraub D; Fan Y
    Brain Imaging Behav; 2020 Oct; 14(5):1445-1455. PubMed ID: 31011947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exchangeable copper: a reflection of the neurological severity in Wilson's disease.
    Poujois A; Trocello JM; Djebrani-Oussedik N; Poupon J; Collet C; Girardot-Tinant N; Sobesky R; Habès D; Debray D; Vanlemmens C; Fluchère F; Ory-Magne F; Labreuche J; Preda C; Woimant F
    Eur J Neurol; 2017 Jan; 24(1):154-160. PubMed ID: 27739240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional morphometric abnormalities and clinical relevance in Wilson's disease.
    Zou L; Song Y; Zhou X; Chu J; Tang X
    Mov Disord; 2019 Apr; 34(4):545-554. PubMed ID: 30817852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wilson's disease: update on pathogenesis, biomarkers and treatments.
    Shribman S; Poujois A; Bandmann O; Czlonkowska A; Warner TT
    J Neurol Neurosurg Psychiatry; 2021 Oct; 92(10):1053-1061. PubMed ID: 34341141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis.
    Siller N; Kuhle J; Muthuraman M; Barro C; Uphaus T; Groppa S; Kappos L; Zipp F; Bittner S
    Mult Scler; 2019 Apr; 25(5):678-686. PubMed ID: 29542376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between neuroimaging, neurological phenotype, and functional outcomes in Wilson's disease.
    Moura J; Pinto C; Freixo P; Alves H; Ramos C; Santos Silva E; Nery F; Gandara J; Lopes V; Ferreira S; Presa J; Ferreira JM; Miranda HP; Magalhães M
    Neurol Sci; 2024 Jul; 45(7):3201-3208. PubMed ID: 38291197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative assessment of clinical rating scales in Wilson's disease.
    Volpert HM; Pfeiffenberger J; Gröner JB; Stremmel W; Gotthardt DN; Schäfer M; Weiss KH; Weiler M
    BMC Neurol; 2017 Jul; 17(1):140. PubMed ID: 28732478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of treatment on blood-brain barrier impairment in Wilson's disease.
    Misztal M; Członkowska A; Cudna A; Palejko A; Litwin T; Piechal A; Kurkowska-Jastrzębska I
    Neurol Neurochir Pol; 2023; 57(4):379-386. PubMed ID: 37526174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.